Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
NeuroPace Inc (NPCE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2021 |
4/A
| Favet Michael (CEO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 27,000 shares
@ $0
Granted 54,000 options to buy
@ $21.67, valued at
$1.2M
|
|
| 06/29/2021 |
4/A
| Morrell Martha (Chief Medical officer) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 8,310 shares
@ $0
Granted 16,620 options to buy
@ $21.67, valued at
$360.2k
|
|
| 06/29/2021 |
4/A
| Kuhn Rebecca (CFO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 8,310 shares
@ $0
Granted 16,620 options to buy
@ $21.67, valued at
$360.2k
|
|
| 06/29/2021 |
4/A
| Ridley Irina (General Counsel and Secretary) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 5,770 shares
@ $0
Granted 11,540 options to buy
@ $21.67, valued at
$250.1k
|
|
|
|